Aminobenzoic acids and derivatives
Aobchem 3-Amino-4 6-dibromo-2-methylbenzoic acid | ≥97% | CAS 1935932-87-8 | C8H7Br2NO2 | 1g
3-Amino-4 6-dibromo-2-methylbenzoic acid | ≥97% | CAS 1935932-87-8 | C8H7Br2NO2 | 1g
Chemscene 4 4-Difluorocyclohexanecarboxylic acid | 10g | CS-D1695 | 98% | 122665-97-8 | MFCD03788493 | 164 15 | C7H10F2O2
Chemscene | 4 4-Difluorocyclohexanecarboxylic acid | 10g | CS-D1695 | 98% | 122665-97-8 | MFCD03788493 | 164 15 | C7H10F2O2
Aobchem 4-Bromo-2 5-dimethylbenzoic acid | ≥97% | CAS 276677-03-3 | C9H9BrO2 | 1g
4-Bromo-2 5-dimethylbenzoic acid | ≥97% | CAS 276677-03-3 | C9H9BrO2 | 1g
Aobchem 4-Bromo-2 5-dimethylbenzoic acid | ≥97% | CAS 276677-03-3 | C9H9BrO2 | 5g
4-Bromo-2 5-dimethylbenzoic acid | ≥97% | CAS 276677-03-3 | C9H9BrO2 | 5g
Aobchem 3-Bromo-2-fluoro-4-methylbenzoic acid | ≥95% | CAS 1427382-06-6 | C8H6BrFO2 | 5g
3-Bromo-2-fluoro-4-methylbenzoic acid | ≥95% | CAS 1427382-06-6 | C8H6BrFO2 | 5g
Promega Corporation Lumit(R) VEGF-A (Human) Immunoassay 500 assays
Lumit(R) VEGF-A (Human) Immunoassay 500 assays
Chemscene (S)-(-)-3 3 -Dibromo-1 1 -bi-2-naphthol | 5g | CS-0031302 | 98% | 119707-74-3 | MFCD03093629 | 444 12 | C20H12Br2O2
Chemscene | (S)-(-)-3 3 -Dibromo-1 1 -bi-2-naphthol | 5g | CS-0031302 | 98% | 119707-74-3 | MFCD03093629 | 444 12 | C20H12Br2O2
eMolecules 27492-84-8 | 2-Methoxy-4-aminobenzoic acid methyl ester | Chem-Impex | MFCD00017202 | 181.191 | C9H11NO3 | 98.000 | COC(=O)c1ccc(N)cc1OC | 1kg | 489819597
2-Methoxy-4-aminobenzoic acid methyl ester | Chem-Impex | 27492-84-8 | MFCD00017202 | 181.191 | C9H11NO3 | 98.000 | COC(=O)c1ccc(N)cc1OC | 1kg | 489819597
Chemscene 3-Chloro-4-(trifluoromethoxy)benzonitrile | 5g | CS-W013129 | 98% | 129604-26-8 | MFCD01631557 | 221 56 | C8H3ClF3NO
Chemscene | 3-Chloro-4-(trifluoromethoxy)benzonitrile | 5g | CS-W013129 | 98% | 129604-26-8 | MFCD01631557 | 221 56 | C8H3ClF3NO
Apexbio Technology LLC Purvalanol A 212844-53-6 10mM (in 1mL DMSO)
Purvalanol A (CAS 212844-53-6) is a potent and selective inhibitor of cyclin-dependent kinases (CDKs) exhibiting IC50 values of 4 nM for cdc2-cyclin B 35 nM for CDK2-cyclin E 70 nM for CDK2-cyclin A 75 nM for CDK5-p35 and 850 nM for CDK4-cyclin D1 By targeting CDKs Purvalanol A disrupts cell cycle regulation transcription and neuronal differentiation processes In cellular studies it decreases levels of anti-apoptotic proteins and induces apoptosis partly through inhibition of JAK2/STAT3 signaling and RNA polymerase II phosphorylation Additionally Purvalanol A modulates polyamine catabolic pathways and affects cell proliferation in neural tissues supporting its utility in cell cycle apoptosis and neurobiology research
Chemscene 2-(Trifluoromethyl)pyridin-3-amine | 1g | CS-0005619 | 98% | 106877-32-1 | MFCD09753488 | 162 11 | C6H5F3N2
Chemscene | 2-(Trifluoromethyl)pyridin-3-amine | 1g | CS-0005619 | 98% | 106877-32-1 | MFCD09753488 | 162 11 | C6H5F3N2
Chemscene 9 10-Bis(phenylethynyl)anthracene | 100g | CS-0010178 | 97% | 10075-85-1 | MFCD00012050 | 378 46 | C30H18
Chemscene | 9 10-Bis(phenylethynyl)anthracene | 100g | CS-0010178 | 97% | 10075-85-1 | MFCD00012050 | 378 46 | C30H18
Chemscene Indoximod | 5g | CS-4941 | 98% | 110117-83-4 | MFCD00274271 | 218 26 | C12H14N2O2
Chemscene | Indoximod | 5g | CS-4941 | 98% | 110117-83-4 | MFCD00274271 | 218 26 | C12H14N2O2